He claims to have already produced “several hundred thousand doses” in a factory in Puurs, Belgium, and thinks he can put an end to the Covid-19 nightmare.
It plans to produce 100 million doses of the vaccine by the end of the year – 40 million of which are reportedly planned for the UK.
Ben Osborn, CEO of Pfizer UK, said: “It was great to see the first bottle roll off the production line.
“It gave me a great smile to see all this work lead to a product,” he added to the Sunday Mail.
Pfizer, which is developing the vaccine alongside its German partner BioNTech, said it could confirm whether the vaccine is effective this month – but it needs safety data from a clinical trial of 44,000 people.
Managing Director Albert Bourla wrote on Friday: “So let me be clear, assuming positive data, Pfizer will apply for emergency clearance in the United States shortly after the safety milestone is reached in the third week of November. ”
Earlier this month, the FDA made it mandatory for vaccine manufacturers to collect two months of safety data on half of the trial participants.
Earlier today, SAGE adviser Professor Jeremy Farrar said he believed a vaccine would be available in the first trimester of next year.
He told Sky’s Sophie Ridge: “I believe vaccines will be available in the first quarter of next year, I believe monoclonal antibodies to treat patients and save lives will be available in the coming months.
“It is in this context that I think we need to reduce transmission now and that we need to get back to the beginning of September as a country, not piecemeal, not in fragments across the country, but in its together.
It comes after Professor Jonathan Van-Tam reportedly told MPs that a stunt produced by the University of Oxford and drug giant AstraZenica could be rolled out by December.
According to The Times, he told MPs: “We are not light years away. It’s not a totally unrealistic suggestion that we could roll out a vaccine soon after Christmas.
“It would have a significant impact on hospitalizations and deaths. “